| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.093 | 0.009 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.01 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.068 | 0.01 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |